Skip to main content
Industry News
Testosterone therapy may cut T2D risk in adult men

Adult men with impaired glucose tolerance or recently diagnosed diabetes but no pathological hypogonadism who took 1,000 mg of testosterone undecanoate and underwent a lifestyle program from WW for two years had a lower risk for type 2 diabetes, compared with those who took placebo and participated in the lifestyle program, according to a study in The Lancet Diabetes & Endocrinology. Men in the testosterone therapy group had bigger declines in waist circumference, total fat mass, abdominal fat mass and fasting glucose, while those treated with placebo had a decrease in total muscle mass, arm muscle mass and hand-grip strength.

Full Story: